Research and development focused on safety, abundance, enjoyment and environmental responsibility
First written in FY2016. 22 of 25 entries say "Restated". Latest entry: FY2026.
6 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Total R&D expenses incurred by the Group during the fiscal year were ¥343 million.」
The R&D policy focused on safety, quality of life, enjoyment and environmental considerations continued, and R&D expenses increased from ¥295 million in the previous fiscal year to ¥343 million. - FY2024RestatedAnnual report
「The Group, comprising the Company and its consolidated subsidiaries, conducts broad-ranging R&D activities, from developing new food ingredients and products to developing environmentally considerate compound feed, based on the fundamental policy of making meals in Japan safe, wholesome and enjoyable.」
The R&D policy focused on safety, quality of life, enjoyment and environmental considerations continued. R&D expenses decreased to ¥295 million from ¥304 million in the previous fiscal year. - FY2024-Q3RestatedAnnual report
「Total R&D expenses for the nine-month cumulative consolidated period were ¥227 million. There were no material changes in the status of the Group's R&D activities during the nine-month cumulative consolidated period.」
There were no material changes in R&D activities, and R&D expenses for the nine-month cumulative period were stated at ¥227 million. - FY2024-Q1RestatedAnnual report
「Total R&D expenses for the three-month cumulative consolidated period were ¥86 million. There were no material changes in the status of the Group's R&D activities during the three-month cumulative consolidated period.」
No material changes in R&D activities were confirmed, and R&D expenses for the three-month cumulative period were stated at ¥86 million. - FY2023RestatedAnnual report
「The Group, comprising the Company and its consolidated subsidiaries, conducts broad-ranging R&D activities, from developing new food ingredients and products to developing environmentally considerate compound feed, based on the fundamental policy of making meals in Japan safe, wholesome and enjoyable.」
The R&D policy focused on safety, quality of life, enjoyment and environmental considerations continued. R&D expenses were stated at ¥304 million. - FY2023-Q3RestatedAnnual report
「Total R&D expenses for the nine-month cumulative consolidated period were ¥319 million. There were no material changes in the status of the Group's R&D activities during the nine-month cumulative consolidated period.」
There were no material changes in R&D activities, and R&D expenses for the nine-month cumulative consolidated period were stated at ¥319 million. - FY2023-Q2RestatedAnnual report
「Total R&D expenses for the six-month cumulative consolidated period were ¥210 million. There were no material changes in the status of the Group's R&D activities during the six-month cumulative consolidated period.」
There were no material changes in R&D activities, and R&D expenses for the six-month cumulative consolidated period were stated at ¥210 million. - FY2022RestatedAnnual report
「The Group, comprising the Company and its consolidated subsidiaries, conducts broad-ranging R&D activities, from developing new food ingredients and products to developing environmentally considerate compound feed, based on the fundamental policy of making meals in Japan safe, wholesome and enjoyable.」
The broad R&D policy focused on safety, quality of life, enjoyment and environmental considerations continued. R&D expenses were stated at ¥428 million. - FY2022-Q3RestatedAnnual report
「Total R&D expenses for the nine-month cumulative consolidated period were ¥310 million. There were no material changes in the status of the Group's R&D activities during the nine-month cumulative consolidated period.」
There were no material changes in R&D activities, and R&D expenses for the nine-month cumulative period were stated at ¥310 million. - FY2022-Q2RestatedAnnual report
「Total R&D expenses for the six-month cumulative consolidated period were ¥201 million. There were no material changes in the status of the Group's R&D activities during the six-month cumulative consolidated period.」
No material changes in R&D activities were confirmed, and R&D expenses for the six-month cumulative consolidated period were stated at ¥201 million. - FY2021RestatedAnnual report
「The Group, comprising the Company and its consolidated subsidiaries, conducts broad-ranging R&D activities, from developing new food ingredients and products to developing environmentally considerate compound feed, based on the fundamental policy of making meals in Japan safe, wholesome and enjoyable.」
The broad R&D policy focused on safety, quality of life, enjoyment and environmental considerations continued. R&D personnel totaled 69, and R&D expenses were stated at ¥440 million. - FY2021-Q3RestatedAnnual report
「Total R&D expenses for the nine-month cumulative consolidated period were ¥329 million.」
Research and development activities continued, with total R&D expenses for the nine-month cumulative consolidated period stated at ¥329 million. - FY2020AdvancedAnnual report
「The R&D structure is led by the Company's Development Department, Quality Assurance Department, Quality Control Section, Business Development Section, Product Development Section, Research Section, Fisheries Research Center, Livestock and Fish Clinic, and the R&D division of 林兼フーズ株式会社. The Group had 86 R&D personnel, and total R&D expenses for the fiscal year were ¥551 million.」
R&D personnel increased from 82 in the previous fiscal year to 86, while R&D expenses increased from ¥514 million to ¥551 million. - FY2020-Q3RestatedAnnual report
「Total R&D expenses for the nine-month cumulative consolidated period were ¥400 million.」
Research and development activities continued, with total R&D expenses for the nine-month cumulative consolidated period stated at ¥400 million. - FY2020-Q2RestatedAnnual report
「Total R&D expenses for the six-month cumulative consolidated period were ¥265 million.」
Research and development activities continued, with R&D expenses for the six-month cumulative consolidated period stated at ¥265 million. - FY2019RestatedAnnual report
「The R&D structure is led by the Company's Development Department, Quality Assurance Department, Quality Control Section, Business Development Section, Product Development Section, Research Section, Fisheries Research Center, Livestock and Fish Clinic, and the R&D division of 林兼フーズ株式会社. The Group had 82 R&D personnel, and total R&D expenses for the fiscal year were ¥514 million.」
R&D focused on safety, quality of life, enjoyment and environmental considerations continued, with 82 R&D personnel and R&D expenses of ¥514 million stated. - FY2019-Q3RestatedAnnual report
「Total R&D expenses for the nine-month cumulative consolidated period were ¥380 million.」
Research and development activities continued, with total R&D expenses for the nine-month cumulative consolidated period stated at ¥380 million. - FY2019-Q1RestatedAnnual report
「Total R&D expenses for the six-month cumulative consolidated period were ¥122 million.」
Research and development activities continued, with total R&D expenses for the first quarter stated at ¥122 million. - FY2018-Q3RestatedAnnual report
「Total R&D expenses for the nine-month cumulative period were ¥373 million.」
Research and development activities continued, with total R&D expenses for the nine-month cumulative consolidated period stated at ¥373 million. - FY2018-Q2RestatedAnnual report
「Total R&D expenses for the six-month cumulative period were ¥244 million.」
The company continues its R&D activities and reports R&D expenses of ¥244 million for the six-month cumulative period. - FY2018-Q1RestatedAnnual report
「Total R&D expenses for the three-month cumulative period were ¥119 million.」
The company continues its R&D activities and reports total R&D expenses of ¥119 million for the quarter. - FY2017RestatedAnnual report
「Our group, consisting of the company and its consolidated subsidiaries, conducts a broad range of research and development activities, from developing new food materials and products to developing environmentally responsible compound feed, under the basic policy of making Japanese dining tables safe, abundant and enjoyable. R&D is led by the company's Development Department, Quality Assurance Department, Quality Control Section, Business Development Section, Product Development Section, Research Section, Fisheries Research Center, Livestock and Fish Clinic, and the R&D departments of each subsidiary. The group has 72 R&D personnel. Group-wide R&D expenses for the fiscal year were ¥494 million.」
The company continues its R&D policy focused on safety, abundance, enjoyment and environmental responsibility, and reports 72 R&D personnel and ¥494 million in R&D expenses. - FY2017-Q3RestatedAnnual report
「Total R&D expenses for the nine-month cumulative period were ¥360 million.」
The company continues its R&D activities and reports total R&D expenses of ¥360 million. - FY2017-Q2RestatedAnnual report
「(5) Research and Development Activities Total R&D expenses for the six-month cumulative period were ¥236 million.」
The company continues its R&D activities and reports R&D expenses of ¥236 million for the six-month cumulative period. - FY2016First statedAnnual report
「Our group, consisting of the company and its consolidated subsidiaries, conducts a broad range of research and development activities, from developing new food materials and products to developing environmentally responsible compound feed, under the basic policy of making Japanese dining tables safe, abundant and enjoyable. R&D is led by the company's Development Department, Quality Assurance Department, Quality Control Section, Business Development Section, Product Development Section, Research Section, Fisheries Research Center, Livestock and Fish Clinic, and the R&D departments of each subsidiary. The group has 73 R&D personnel. Group-wide R&D expenses for the fiscal year were ¥495 million, and the purpose, key issues, results and R&D expenses of research in each segment are as follows.」
The company reports its basic R&D policy, structure, 73 personnel and ¥495 million in R&D expenses.